Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
KPTI compared with OKUR: revenue, margins and what each company keeps, and the suppliers and customers both name
KPTI
Karyopharm Therapeutics Inc.
Change
Mkt cap
Revenue
Revenue
OKUR
OnKure Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
KPTI
Karyopharm Therapeutics Inc.
vs
OKUR
OnKure Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
KPTI, solid
OKUR, dashed
Supply-chain overlap
Revenue flow
KPTI: latest quarter is a loss; flow not drawable. OKUR: latest quarter not drawable.
Method
›
KPTI
Karyopharm Therapeutics Inc.
Change
0.63
· pre 0.65
· delayed
Mkt cap
$15.0M
Revenue
$33M
Q2 FY26
Revenue
$146M
FY25
OKUR
OnKure Therapeutics, Inc.
Change
2.63
· pre 2.63
· delayed
Pre-market
Oct 30 '26
delayed
Mkt cap
$106.1M
Revenue
—
Revenue
—
vs
Compare
Pre-market
Oct 30 '26
delayed
KPTI
Karyopharm Therapeutics Inc.
vs
OKUR
OnKure Therapeutics, Inc.
0.63
pre 0.65
delayed
Price
2.63
pre 2.63
delayed
$15.0M
Mkt cap
$106.1M
Q2 FY26
$33M
Revenue
—
FY25
$146M
Revenue
—
Change
Change
KPTI
0.63
vs
OKUR
2.63
Pre-market
Oct 30 '26
delayed
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only KPTI
6
BMY
Bristol-Myers Squibb
supplier
—
FORUS Therapeutics
unlisted
customer
—
Menarini
unlisted
customer
—
Antengene Therapeutics
unlisted
customer
2 more · KPTI chain
›
Shared
0
No shared counterparties.
Only OKUR
2
—
PharmaBlock Sciences (Nanjing)
unlisted
supplier
—
STA Pharmaceutical Hong Kong
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR